Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC

by /u/montaukwhaler in /r/nsclc

Upvotes: 2

Favorite this post:

Mark as read:

Your rating:

Add this post to a custom list